Cargando…
A low molecular weight multifunctional theranostic molecule for the treatment of prostate cancer
Rationale: Although surgery and radiation therapy in patients with low risk prostate cancer appear appropriate and effective, those with high-risk localized disease almost always become hormone refractory and then rapidly progress. A new treatment strategy is urgently needed for patients with high-r...
Autores principales: | Wang, Xinning, Sun, Rongcan, Wang, Jing, Li, Jing, Walker, Ethan, Shirke, Aditi, Ramamurthy, Gopolakrishnan, Shan, Lingpeng, Luo, Dong, Carmon, Lauren, Basilion, James P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899574/ https://www.ncbi.nlm.nih.gov/pubmed/35265213 http://dx.doi.org/10.7150/thno.68715 |
Ejemplares similares
-
Small Molecule-Based Prodrug Targeting Prostate Specific Membrane Antigen for the Treatment of Prostate Cancer
por: Wang, Xinning, et al.
Publicado: (2021) -
Ultrasound-mediated drug-free theranostics for treatment of prostate cancer
por: Perera, Reshani Himashika, et al.
Publicado: (2023) -
Prostate-specific membrane antigen targeted gold nanoparticles for prostate cancer radiotherapy: does size matter for targeted particles?
por: Luo, Dong, et al.
Publicado: (2019) -
Molecular imaging of orthotopic prostate cancer with nanobubble ultrasound contrast agents targeted to PSMA
por: Wang, Yu, et al.
Publicado: (2021) -
Theranostic applications of multifunctional carbon nanomaterials
por: Asil, Shima Masoudi, et al.
Publicado: (2023)